May 31, 2025
Treatment with pembrolizumab and the antibody-drug conjugate (ADC) sacituzumab govitecan improved progression-free survival (PFS) in patients with PD-L1-positive locally advanced or metastatic triple-negative breast cancer (TNBC) […]
May 30, 2025
TOPLINE: At a median follow-up of 13.2 years, dose-escalated hypofractionated intensity-modulated radiation therapy led to fewer treatment failures in men with localized, intermediate-risk prostate cancer than […]
May 29, 2025
In 2005, Roy Brosgole, then 38, was a busy working parent. He commuted about an hour each way to a teaching job in New York City […]
May 29, 2025
Pfizer was taken to task at a recent meeting of the US Food and Drug Administration (FDA)’s Oncologic Drugs Advisory Committee (ODAC) for attempting to expand […]
May 29, 2025
(Reuters) -Merck and Japan-based Daiichi Sankyo have withdrawn their U.S. application for an experimental lung cancer treatment after it failed to prolong the lives of patients […]
May 29, 2025
More than 60% of patients with cervical cancer and 30% of those with endometrial cancer are diagnosed at an advanced stage, when survival rates are lowest. […]
May 29, 2025
TOPLINE: Compared with digital mammography, digital breast tomosynthesis (also known as 3D mammography) improved specificity and reduced recall rates in women with a family history of […]
May 28, 2025
New data suggest that glucagon-like peptide 1 (GLP-1) receptor agonists, used to treat diabetes and obesity, may also help guard against obesity-related cancers. In a large […]
May 27, 2025
Supplemental imaging techniques could more than triple cancer detection in dense breasts compared with standard care alone, according to new research. The study, published in The […]